VANGUARD GROUP INC 13D and 13G filings for ArriVent BioPharma, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-30 1:28 pm Sale | 2025-12-31 | 13G | ARRIVENT BIOPHARMA INC AVBP | VANGUARD GROUP INC | 1,869,266 4.520% | -160,265 (-7.90%) | Filing |
| 2025-10-30 2:04 pm Purchase | 2025-09-30 | 13G | ARRIVENT BIOPHARMA INC AVBP | VANGUARD GROUP INC | 2,029,531 5.000% | 2,029,531 (New Position) | Filing |